Ann: Leads investment into Sky Mavis, maker of Axie Infinity, page-232

First 232 Last

Share
Profile

Follow
Mom88

1,597 Posts.

386

25/07/21

15:07

Post #: 54756188
Share

Originally posted by crem: ↑

In April, Axie did about $670k in revenue.

In May, it did $3.0 million.

In June, $12.2 million.
In July, just 18 days into the month, it’s already at $79 million.
Delphi Digital projects that it will close this month at $153 million.

The growth probably can't continue at the rate it has indefinitely. Current run rate for venue is just under 2bn. However, likely to be on for far more than that in a couple of months. I thought it was hyperbole but it could legitimately be one of the highest earning games in the world in a few months - it's not even on Google play or Apple store yet. It's still in early early stages.

What revenue multiple do you apply when it's quadrupling each month? 20x? If so this game's worth north of 50bn already. Make the multiple 10x and our stake 2% and our share is worth what 0.4bn?

Our 2-5% stake is already worth north of a billion imo.

Expand

Yeah quite likely Animoca’s current stake is worth in the B.
I think they will also own a billion in sand assets the way it’s going. Revv, Tower, GMEE, Lym and LMT all going nuts too.
Bring on the next raise at $5+ Imo

AB1 Price at posting: 18.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 232 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: Leads investment into Sky Mavis, maker of Axie Infinity, page-232

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News